Results of the current study demonstrate that trastuzumab treatment reduced p73 expression in YAP-knockdown BT474-TS cells as compared to that in controls, indicating that YAP-knockdown could attenuate the effects of trastuzumab on the p73-induced apoptosis pathway in HER2-positive breast carcinoma cells. Here, YAP1 is linked to breast carcinoma.